An Open-label Phase 2 Study of Eneboparatide, a Novel PTH Receptor 1 Agonist, in Hypoparathyroidism.

Autor: Takacs I; Department of Internal Medicine and Oncology, Semmelweis University, 1088 Budapest, Hungary., Mezosi E; Department of Endocrinology, Pecsi Tudomanyegyetem, 7623 Pecs, Hungary., Soto A; Department of Endocrinology and Nutrition, Complejo Hospitalario Universitario A Coruña, 15006 Coruña, Spain., Kamenický P; Physiologie et Physiopathologie Endocriniennes, AP-HP, Hôpital Bicêtre, Service d'Endocrinologie et des Maladies de la Reproduction, Centre de Référence des Maladies Rares du Métabolisme du Calcium et du Phosphate, Université Paris-Saclay, Inserm, 94270 Le Kremlin Bicêtre, France., Figueres L; Department of Nephrology and Clinical Immunology, Centre Hospitalier Universitaire Nantes-Université de Nantes, 44093 Nantes, France., Galvez Moreno MA; Department of Endocrinology and Nutrition, Hospital Universitario Reina Sofía, 14004 Cordoba, Spain., Lemoine S; Department of Nephrologie, Hypertension-dialysis, Hospices Civils de Lyon and Claude Bernard University, 69008 Lyon, France., Borson-Chazot F; Department of Endocrinology, Diabetes and Metabolic Diseases, Hospices Civils de Lyon and Claude Bernard University, 69394 Lyon, France., Capel I; Department of Endocrinology and Nutrition, Parc Tauli University Hospital, 08208 Sabadell, Barcelona, Spain., Ouldrouis T; Amolyt Pharma, 69130 Ecully, France., Lucas N; Amolyt Pharma, 69130 Ecully, France., Allas S; Amolyt Pharma, 69130 Ecully, France., Sumeray M; Amolyt Pharma, 69130 Ecully, France., Ovize M; Amolyt Pharma, 69130 Ecully, France., Mannstadt M; Endocrine Unit, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA.

Publikováno v: The Journal of clinical endocrinology and metabolism [J Clin Endocrinol Metab] 2024 Aug 13; Vol. 109 (9), pp. 2199-2209.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for appendiceal neuroendocrine tumours (aNET).

Autor: Kaltsas, Gregory¹ (AUTHOR) gkaltsas@med.uoa.gr, Walter, Thomas² (AUTHOR), Knigge, Ulrich³ (AUTHOR), Toumpanakis, Christos⁴ (AUTHOR), Santos, Ana P.⁵ (AUTHOR), Begum, Nehara⁶ (AUTHOR), Pape, Ulrich F.⁷ (AUTHOR), Volante, Marco⁸ (AUTHOR), Frilling, Andrea⁹ (AUTHOR), Couvelard, Anne¹⁰ (AUTHOR)

Publikováno v: Journal of Neuroendocrinology. Oct2023, Vol. 35 Issue 10, p1-14. 14p.

PTHrP- induced hypercalcemia in paragangliomas: Tumor dedifferentiation as sign of bad prognosis

Autor: Laguna, Alcantara, Herrera-Martinez, Y, Sanchez-Frias, ME, Galvez-Moreno, MA, Herrera-Martinez, AD

Publikováno v: Endocrinología, Diabetes y Nutrición; 20210101, Issue: Preprints

CD26 is a senescence marker associated with reduced immunopotency of human adipose tissue-derived multipotent mesenchymal stromal cells.

Autor: Psaroudis, Rose Triantafillia¹ (AUTHOR), Singh, Urvashi¹ (AUTHOR), Lora, Maximilien¹ (AUTHOR), Jeon, Peter¹ (AUTHOR), Boursiquot, Abigail¹ (AUTHOR), Stochaj, Ursula² (AUTHOR), Langlais, David^3,4 (AUTHOR), Colmegna, Inés^1,4,5 (AUTHOR) ines.colmegna@mcgill.ca

Publikováno v: Stem Cell Research & Therapy. 7/26/2022, Vol. 13 Issue 1, p1-10. 10p.